ÂÜÀòÂÒÂ×

Martine George is a highly experienced professional in the life sciences sector with a comprehensive background in oncology. Currently serving as a Board Member for OSE Immunotherapeutics and PEGASCY since June 2024, Martine has held numerous board positions, including roles at PHAXIAM Therapeutics, MaaT Pharma, and GamaMabs Pharma. Previously, Martine worked as a Senior Executive Consultant at Global Development Associates, Inc., and has extensive experience at Pfizer as VP of Global Medical Affairs for Oncology. Prior positions include Chief Medical Officer at GPC Biotech, Senior Vice President and Vice President of Oncology at Johnson and Johnson, and Vice President of Clinical Affairs at Ortho Biotech. Martine holds a Doctor of Medicine degree from Pierre and Marie Curie University, earned between 1966 and 1975.